References
-
Tan, G. Y. A. et al. Start a research on biopolymer polyhydroxyalkanoate (PHA): A review. Polymers 6, 706–754 (2014).
-
Mai, J. et al. Synthesis and physical properties of polyhydroxyalkanoate (PHA)-based block copolymers: A review. Int. J. Biol. Macromol. 263, 130204 (2024).
-
Reddy, V. U. N., Ramanaiah, S. V., Reddy, M. V. & Chang, Y.-C. Review of the developments of bacterial medium-chain-length polyhydroxyalkanoates (mcl-PHAs). Bioengineering 9, 225 (2022).
-
Paul, V., Pandhi, S., Mahato, D. K., Agarwal, A. & Tripathi, A. D. Polyhydroxyalkanoates (PHAs) and its copolymer nanocarrier application in cancer treatment: An overview and challenges. Int. J. Biol. Macromol. 277, 134201 (2024).
-
Ben Abdeladhim, R., Reis, J. A., Vieira, A. M. & de Almeida, C. D. Polyhydroxyalkanoates: Medical applications and potential for use in dentistry. Materials 17, 5415 (2024).
-
Getino, L., Martín, J. L. & Chamizo-Ampudia, A. A review of polyhydroxyalkanoates: Characterization, production, and application from waste. Microorganisms 12, 2028 (2024).
-
Cendal, A. I. R. et al. Polyhydroxyalkanoate nanoparticles for strategic drug delivery in cartilage tissue engineering. Osteoarthr. Cartil. 32, S290–S291 (2024).
-
Benedini, L. Polyhydroxyalkanoates based systems: the future of drug delivery and tissue engineering devices. In Bio-Based Nanomaterials (eds. Mishra, A. K. & Hussain, C. M.) 133–169 (Elsevier, Amsterdam, 2022).
-
Papaneophytou, C., Katsipis, G., Halevas, E. & Pantazaki, A. A. Polyhydroxyalkanoates applications in drug carriers. in Biotechnological Applications of Polyhydroxyalkanoates (ed. Kalia, V. C.) 77–124 (Springer, Singapore, 2019).
-
Tang, H. J., Neoh, S. Z. & Sudesh, K. A review on poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) [P(3HB-co-3HHx)] and genetic modifications that affect its production. Front. Bioeng. Biotechnol. 10, 1057067 (2022).
-
Eichelbaum, M., Ende, M., Remberg, G., Schomerus, M. & Dengler, H. J. The metabolism of DL-[14C]verapamil in man. Drug Metab. Dispos. 7, 145–148 (1979).
-
Yousry, C., Amin, M. M., Elshafeey, A. H. & El Gazayerly, O. N. Ultrahigh verapamil-loaded controlled release polymeric beads using superamphiphobic substrate: D-optimal statistical design, in vitro and in vivo performance. Drug Deliv. 25, 1448–1460 (2018).
-
Herman, A. F. & Santos, C. First-pass effect. NCBI Bookshelf (2025).
-
Pridgen, E. M., Alexis, F. & Farokhzad, O. C. Polymeric nanoparticle technologies for oral drug delivery. Clin. Gastroenterol. Hepatol. 12, 1605–1610 (2014).
-
Agrawal, Y. O. et al. Verapamil hydrochloride loaded solid lipid nanoparticles: preparation, optimization, characterisation, and assessment of cardioprotective effect in experimental model of myocardial infarcted rats. Biomed. Pharmacother. 154, 113429 (2022).
-
Li, Y., Abbaspour, M. R., Grootendorst, P. V., Rauth, A. M. & Wu, X. Y. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology. Eur. J. Pharm. Biopharm. 94, 170–179 (2015).
-
Khan, A. A., Abdulbaqi, I. M., Abou Assi, R., Murugaiyah, V. & Darwis, Y. Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation. Nanoscale Res. Lett. 13, 323 (2018).
-
Jawed, S., Sorathiya, A. & Srivastava, A. K. Formulation and evaluation of verapamil loaded hollow microspheres. Int. J. Pharm. Sci. Res. 8, 4213–4221 (2017).
-
Lakshmanan, M., Foong, C. P., Abe, H. & Sudesh, K. Biosynthesis and characterization of co and ter-polyesters of polyhydroxyalkanoates containing high monomeric fractions of 4-hydroxybutyrate and 5-hydroxyvalerate via a novel PHA synthase. Polym. Degrad. Stab. 163, 122–135 (2019).
-
Surendran, A. et al. Can polyhydroxyalkanoates be produced efficiently from waste plant and animal oils?. Front. Bioeng. Biotechnol. 8, 169 (2020).
-
Foong, C. P. et al. A novel and wide substrate specific polyhydroxyalkanoate (PHA) synthase from unculturable bacteria found in mangrove soil. J. Polym. Res. 25, 23 (2017).
-
Aramvash, A., Moazzeni Zavareh, F. & Gholami Banadkuki, N. Comparison of different solvents for extraction of polyhydroxybutyrate from Cupriavidus necator. Eng. Life Sci. 18, 20–28 (2018).
-
Iwanaga, S. Biochemical principle of Limulus test for detecting bacterial endotoxins. Proc. Jpn. Acad. Ser. B 83, 110–119 (2007).
-
Sopyan, I. Y., Gozali, D. O., Kurniawansyah, I. S. & Guntina, R. K. Design-Expert software (DoE): An application tool for optimization in pharmaceutical preparations formulation. Int. J. Appl. Pharm. 14, 55–63 (2022).
-
Chakraborty, P., Dey, S., Parcha, V., Bhattacharya, S. S. & Ghosh, A. Design expert supported mathematical optimization and predictability study of buccoadhesive pharmaceutical wafers of loratadine. Biomed. Res. Int. 2013, 197398 (2013).
-
Struzek, A.-M. & Scherließ, R. Quality by design as a tool in the optimisation of nanoparticle preparation—A case study of PLGA nanoparticles. Pharmaceutics 15, 617 (2023).
-
Narayanan, K., Subrahmanyam, V. M. & Venkata Rao, J. A fractional factorial design to study the effect of process variables on the preparation of hyaluronidase loaded PLGA nanoparticles. Enzyme Res. 2014, 162962 (2014).
-
Lakshmana Prabu, S., Shirwaikar, A. A., Shirwaikar, A. & Kumar, A. Formulation and evaluation of sustained release microspheres of rosin containing aceclofenac. Ars Pharm. 50, 1–12 (2009).
-
Sankar, P. R., Snehalatha, K. S., Firdose, S. T. & Babu, P. S. Applications of HPLC in pharmaceutical analysis. Int. J. Pharm. Sci. Rev. Res. 59, 117–124 (2019).
-
Jain, M. & Shrivastava, S. N. A stability indicating assay method for verapamil tablets by high performance liquid chromatography for stability studies. Anal. Chem. 1, 6–9 (2007).
-
Madhuri, P. L. & Geetha, V. Development and validation of UV spectrophotometric methods. Asian J. Pharm. Anal. Med. Chem. 2, 134–143 (2016).
-
Zhang, S., Prabhakaran, M. P., Qin, X. & Ramakrishna, S. Biocomposite scaffolds for bone regeneration: role of chitosan and hydroxyapatite within poly-3-hydroxybutyrate-co-3-hydroxyvalerate on mechanical properties and in vitro evaluation. J. Mech. Behav. Biomed. Mater. 51, 88–98 (2015).
-
Kaniuk, Ł & Stachewicz, U. Development and advantages of biodegradable PHA polymers based on electrospun PHBV fibers for tissue engineering and other biomedical applications. ACS Biomater. Sci. Eng. 7, 5339–5362 (2021).
-
Ansari, S., Sami, N., Yasin, D., Ahmad, N. & Fatma, T. Biomedical applications of environmental friendly poly-hydroxyalkanoates. Int. J. Biol. Macromol. 183, 549–563 (2021).
-
Trakunjae, C. et al. Statistical optimization of P(3HB-co-3HHx) copolymers production by Cupriavidus necator PHB–4/pBBR_CnPro-phaCRp and its properties characterization. Sci. Rep. 13, 9005 (2023).
-
Tan, F. H. P., Nadir, N. & Sudesh, K. Microalgal biomass as feedstock for bacterial production of PHA: Advances and future prospects. Front. Bioeng. Biotechnol. 10, 879476 (2022).
-
Dullah, E. C. & Ongkudon, C. M. Current trends in endotoxin detection and analysis of endotoxin-protein interactions. Crit. Rev. Biotechnol. 37, 251–261 (2017).
-
Sudesh, K., Abe, H. & Doi, Y. Synthesis, structure and properties of polyhydroxyalkanoates: Biological polyesters. Prog. Polym. Sci. 25, 1503–1555 (2000).
-
Sharma, N., Madan, P. & Lin, S. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study. Asian J. Pharm. Sci. 11, 404–416 (2016).
-
Eslami, M., Nikkhah, S. J., Eslami, E. & Hashemianzadeh, S. M. A new insight into encapsulation process of a drug molecule in the polymer/surfactant system: A molecular simulation study. Struct. Chem. 31, 2051–2062 (2020).
-
Pagliano, G., Galletti, P., Samorì, C., Zaghini, A. & Torri, C. Recovery of polyhydroxyalkanoates from single and mixed microbial cultures: A review. Front. Bioeng. Biotechnol. 9, 1–28 (2021).
-
Zambaux, M. F. et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J. Control. Release 50, 31–40 (1998).
-
Freiberg, S. & Zhu, X. X. Polymer microspheres for controlled drug release. Int. J. Pharm. 282, 1–18 (2004).
-
Govender, T., Stolnik, S., Garnett, M. C., Illum, L. & Davis, S. S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release 57, 171–185 (1999).
-
Jain, R. A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21, 2475–2490 (2000).
-
Prakash, P., Lee, W. H., Loo, C. Y., Wong, H. S. & Parumasivam, T. Advances in polyhydroxyalkanoate nanocarriers for effective drug delivery: An overview and challenges. Nanomaterials 12, 1–20 (2022).
-
Lee, K. H., Khan, F. N., Cosby, L., Yang, G. & Winter, J. O. Polymer concentration maximizes encapsulation efficiency in electrohydrodynamic mixing nanoprecipitation. Front. Nanotechnol. 3, 719710 (2021).
-
Shkodra, B. et al. Effect of surfactant on the size and stability of PLGA nanoparticles encapsulating a protein kinase C inhibitor. Int. J. Pharm. 566, 756–764 (2019).
-
Garms, B. C. et al. Evaluating the effect of synthesis, isolation, and characterisation variables on reported particle size and dispersity of drug loaded PLGA nanoparticles. Mater. Adv. 2, 5657–5671 (2021).
-
Ayoub, M. et al. Study of the effect of formulation parameters/variables to control the nanoencapsulation of hydrophilic drug via double emulsion technique. J. Biomed. Nanotechnol. 7, 255–262 (2011).
-
Ramazani, F. et al. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges. Int. J. Pharm. 499, 358–367 (2016).
-
Ding, S., Serra, C. A., Vandamme, T. F., Yu, W. & Anton, N. Double emulsions prepared by two-step emulsification: History, state-of-the-art and perspective. J. Control. Release 295, 31–49 (2019).
-
Ghazi, N. F., Burley, J. C., Dryden, I. L. & Roberts, C. J. High-throughput microarray approaches for predicting the stability of drug–polymer solid dispersions. Mol. Pharm. 22, 343–362 (2025).
-
Pilanya, U., Pilaniya, K., Chandrawanshi, H. K., Gupta, N. & Rajput, M. S. Formulation and evaluation of verapamil hydrochloride loaded solid lipid microparticles. Pharmazie 66, 24–30 (2011).
-
Mosalam, E. M. et al. Enhanced neuroprotective effect of verapamil-loaded hyaluronic acid modified carbon quantum dots in an in-vitro model of amyloid-induced Alzheimer’s disease. Int. J. Biol. Macromol. 275, 133742 (2024).
-
Faisal, M. M. et al. Verapamil-loaded cubosomes for enhancing intranasal drug delivery: Development, characterization, ex vivo permeation, and brain biodistribution studies. AAPS PharmSciTech 25, 95 (2024).
-
Moeed, A. et al. Verapamil hydrochloride nanoparticles formulated with chitosan and sodium alginate by an ionic gelation method. Trop. J. Pharm. Res. 20, 1105–1111 (2021).
-
Qi, S. et al. Insights into the role of polymer-surfactant complexes in drug solubilisation/stabilisation during drug release from solid dispersions. Pharm. Res. 30, 290–302 (2013).
-
Fischer, K. & Schmidt, M. Pitfalls and novel applications of particle sizing by dynamic light scattering. Biomaterials 98, 79–91 (2016).
-
Stetefeld, J., McKenna, S. A. & Patel, T. R. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys. Rev. 8, 409–427 (2016).
-
Pilaniya, U., Pilaniya, K., Chandrawanshi, H. K., Gupta, N. & Rajput, M. S. Biodegradable solid lipid microparticles loaded with diltiazem hydrochloride for oral delivery: Preparation and in-vitro/in-vivo evaluation. J. Drug Deliv. Ther. 1, 1–6 (2011).
-
Albanese, A., Tang, P. S. & Chan, W. C. W. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1–16 (2012).
-
da Silva, R. Y. P., de Menezes, D. L. B., Oliveira, V. S., Converti, A. & de Lima, Á. A. N. Microparticles in the development and improvement of pharmaceutical formulations: An analysis of in vitro and in vivo studies. Int. J. Mol. Sci. 24, 5441 (2023).
-
Dowdall, N. & Hoare, T. β-1,3-glucan microparticles and nanoparticles: Fabrication methods and applications in immunomodulation and targeted drug delivery. Adv. Healthc. Mater. 14, 2501006 (2025).
-
Fisher, J. D., Acharya, A. P. & Little, S. R. Micro and nanoparticle drug delivery systems for preventing allotransplant rejection. Clin. Immunol. 160, 24–35 (2015).
